Protective effecs of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatohepatitis.